Adriamycin RDF Interactions
There are 608 drugs known to interact with Adriamycin RDF (doxorubicin), along with 4 disease interactions. Of the total drug interactions, 112 are major, 467 are moderate, and 29 are minor.
- View all 608 medications that may interact with Adriamycin RDF
- View Adriamycin RDF disease interactions (4)
Most frequently checked interactions
View interaction reports for Adriamycin RDF (doxorubicin) and the medicines listed below.
- Adcetris (brentuximab)
- Avastin (bevacizumab)
- Baraclude (entecavir)
- BeneFix (coagulation factor ix)
- Besponsa (inotuzumab ozogamicin)
- Blenoxane (bleomycin)
- bleomycin
- Blincyto (blinatumomab)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Cimzia (certolizumab)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Crixivan (indinavir)
- Cytoxan (cyclophosphamide)
- Dexedrine (dextroamphetamine)
- Empliciti (elotuzumab)
- Enbrel (etanercept)
- Etopophos (etoposide)
- etoposide
- Kalydeco (ivacaftor)
- Matulane (procarbazine)
- Meticorten (prednisone)
- Mustargen (mechlorethamine)
- Norvir (ritonavir)
- Oncovin (vincristine)
- prednisone
- Rescriptor (delavirdine)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecentriq (atezolizumab)
Adriamycin RDF disease interactions
There are 4 disease interactions with Adriamycin RDF (doxorubicin) which include:
Report options
More about Adriamycin RDF (doxorubicin)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.